Patents by Inventor Warren J Rowe

Warren J Rowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11864811
    Abstract: A method for performing cold atmospheric plasma therapy to treat breast cancer. The cancerous tumor is sampled and cold atmospheric plasma treatment is performed on sampled cancerous tumor cells ex vivo. The results of the testing are stored in an electronic storage media. A cell viability reduction rate of said tested samples is calculated with a processor and stored in memory. An average cell viability reduction rate is then calculated by the processor for the cancerous tumor. Cold atmospheric plasma dosages to be used in treatment of the cancerous tumor in vivo are then projected using the processor. The tumor is surgically removed from the patient. The surgical margins of the tumor are then treated with cold atmospheric plasma at the projected dosages.
    Type: Grant
    Filed: August 22, 2019
    Date of Patent: January 9, 2024
    Assignee: US Patent Innovations, LLC
    Inventors: Xiaoqian Cheng, Jerome Canady, Warren J Rowe
  • Publication number: 20200060748
    Abstract: A method for performing cold atmospheric plasma therapy to treat breast cancer. The cancerous tumor is sampled and cold atmospheric plasma treatment is performed on sampled cancerous tumor cells ex vivo. The results of the testing are stored in an electronic storage media. A cell viability reduction rate of said tested samples is calculated with a processor and stored in memory. An average cell viability reduction rate is then calculated by the processor for the cancerous tumor. Cold atmospheric plasma dosages to be used in treatment of the cancerous tumor in vivo are then projected using the processor. The tumor is surgically removed from the patient. The surgical margins of the tumor are then treated with cold atmospheric plasma at the projected dosages.
    Type: Application
    Filed: August 22, 2019
    Publication date: February 27, 2020
    Inventors: Xiaoqian Cheng, Jerome Canady, Warren J Rowe